OSI PHARMACEUTIC OSIP (NASDAQ)

$ 49.92
19:10
Change: unch (unch%)
Volume: 1,143,784

Avg. Volume: 1383749
P/E Ratio: 26
EPS (Annual): 1.49
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 57,120
Institutional Shareholders: 84.20%
Last: 49.92
Change: unch (unch%)
Prev. Close: 49.92
Open: 50.73
Day's Range: 49.50 - 50.90
52wk Range: 28.68 - 52.00
Market Value: 2,760,330
Beta: -.13
12-month EPS Change: -131.41%
Total Return Last 12 Months: +51.27%
Total Return Last 3 Years: +16.00%
Total Return Last 5 Years: +53.27%
5-Year Revenue Growth Rate: 1463.21%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -118.95%


Headlines on OSIP
Alert me Subscribe

Movers roundup: SunOpta, Opnext

Among the stock activity stories for Friday, June 27, from AP Financial News: NEW YORK (AP)--Shares of SunOpta Inc., which sells personal care products and natural and organic food...READ MORE
Jun 27, 2008 2:40PM
Keywords: STKL, OPXT, EXP, ACN, OSIP

OSI shares rise on Weisel "Overweight" rating

(NEW YORK)Shares of OSI Pharmaceuticals Inc. rose Friday after a Thomas Weisel Partners analysts initiated coverage of the biopharmaceutical company with an "Overweight" rating, citing accel...READ MORE
Jun 27, 2008 12:09PM
Keywords: OSIP, DNA, AZN, LLY, BMY, IMCL

Sector Snap: Biotech _ large-cap or small-cap?

(NEW YORK)Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesd...READ MORE
Jun 24, 2008 12:51PM
Keywords: DNA, CELG, GILD, UTHR, BIOD, CEPH, AMGN, IMCL, BIIB, GENZ, AMLN, ALKS, OSIP

Sector Wrap: Celgene, Genentech in ASCO spotlight

(NEW YORK)Analysts said Celgene Corp. and Genentech Inc. are their top picks heading into the 44th annual American Society of Clinical Oncology meeting, or ASCO, taking place May 30 to June ...READ MORE
May 16, 2008 4:04PM
Keywords: CELG, DNA, IMCL, AMGN, ARIA, CGRB, EXEL, GENZ, IMGN, OSIP, PARD

OSI shares rise after posting 1Q profit on cancer drug sales

(NEW YORK)Shares of OSI Pharmaceuticals rose Wednesday, a day after the biotechnology company beat Wall Street expectations on higher sales of its cancer drug Tarceva.READ MORE
May 07, 2008 4:56PM
Keywords: DNA, AZN, OSIP, BMY, IMCL, LLY

OSI to Pay $500K to Settle Lawsuit

(MELVILLE, N.Y.)OSI Pharmaceuticals Inc. said Friday it expects to pay $500,000 to settle a class-action lawsuit related to its Tarceva lung-cancer drug. OSI's full preliminary settlement amount i...READ MORE
Mar 14, 2008 4:25PM
Keywords: OSIP

Abbott Working on Lung Cancer Test

(DES PLAINES, Ill.)Health care company Abbott Laboratories said Friday it will work with Genentech Inc., F. Hoffmann-La Roche Ltd. and OSI Pharmaceuticals Inc. to develop a gene test to potentially d...READ MORE
Mar 07, 2008 9:56AM
Keywords: ABT, DNA, OSIP
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +6.50 53.92
GILEAD SCIENCES +37.60 52.70
GENENTECH INC +36.30 93.73
CELGENE CP +22.00 70.45
BIOGEN IDEC INC +29.90 71.38